EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity

Caleb A Padgett iD, Joshua T Butcher iD, Sebastian Larion, James D Mintz, David J R Fulton iD, David W Stepp

Antioxidants · 01.01.2026 · 15 (1) · 60

DOI: 10.3390/antiox15010060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 01.01.2026. Verfasst von Caleb A Padgett und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a foremost risk factor for the development of cardiovascular disease, a hallmark of which is chronic vascular inflammation and overproduction of reactive oxygen species (ROS). NADPH oxidases (NOX) are central mediators of ROS overproduction in the obese vasculature, yet a complete understanding of the mechanism underlying their dysregulation in obesity remains poorly understood. Herein, we investigated the contribution of NOX1 in obesity-associated hypertension and evaluated the therapeutic potential of pharmacologically targeting NOX1 using the novel inhibitor GKT771. In obese db/db mice, NOX1 deletion ameliorated hypertension independent of metabolic improvements such as weight loss or improved glucose handling. Furthermore, NOX1 deletion improved renal sodium handling with no compensatory upregulation of other NOX isoforms. Importantly, treatment with the NOX1-specific inhibitor GKT771 rescued endothelial function in obese mice, restoring microvascular function to levels observed in lean controls. These data highlight the importance of NOX1 as a driver of endothelial dysfunction in obesity and suggest that NOX1 inhibition may offer a novel therapeutic strategy for obesity-associated endothelial dysfunction and its downstream cardiovascular complications.

Schlagwörter

Stichwörter der Autor:innen

NADPH oxidasemetabolismphysiologyreactive oxygen speciesvascular biology

Autor:innen und Institutionen

  • Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Department of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

ORCID-Profile: Caleb A Padgett, Joshua T Butcher, David J R Fulton

Zitieren

APA

Padgett, C. A., Butcher, J. T., Larion, S., Mintz, J. D., Fulton, D. J. R., & Stepp, D. W. (2026). NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity. Antioxidants, 15(1), 60. https://doi.org/10.3390/antiox15010060

Vancouver

Padgett CA, Butcher JT, Larion S, Mintz JD, Fulton DJR, Stepp DW. NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity. Antioxidants. 2026;15(1):60. doi:10.3390/antiox15010060

BibTeX
@article{Padgett2026,
  author = {Padgett, Caleb A and Butcher, Joshua T and Larion, Sebastian and Mintz, James D and Fulton, David J R and Stepp, David W},
  title = {NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {60},
  doi = {10.3390/antiox15010060}
}
Kostenlos starten →